Cumberland Pharmaceuticals Inc. Operating Cash Flow
Cumberland Pharmaceuticals Inc. (CPIX) reported Operating Cash Flow of $555.76 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $168.74K, a 80.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $387.02K, a 90.07% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $3.02K, a 99.84% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $187.18K, a 60.64% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2025 was $4.93M.
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$612.19K, a 110.05% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2023 was $6.09M, a 27.91% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2022 was $8.45M, a 33.28% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $168.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $555.76K 10-Q · filed 2026-08-07 | $558.79K derived: sum of 3 quarters · filed 2026-08-07 | $745.97K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $387.02K 10-Q · filed 2026-05-08 | $390.05K derived: sum of 2 quarters · filed 2026-05-08 | $577.23K derived: sum of 3 quarters · filed 2026-05-08 | $1.42M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $190.20K derived: sum of 2 quarters · filed 2026-03-09 | $1.03M derived: sum of 3 quarters · filed 2026-08-07 | $4.93M 10-K · filed 2026-03-09 |
| 2025-09-30 | $187.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.03M derived: sum of 2 quarters · filed 2026-08-07 | $4.93M 10-Q · filed 2025-11-07 | $6.83M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $843.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $4.74M 10-Q · filed 2026-08-07 | $6.65M derived: sum of 3 quarters · filed 2026-08-07 | $7.12M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.90M 10-Q · filed 2026-05-08 | $5.80M derived: sum of 2 quarters · filed 2026-05-08 | $6.28M derived: sum of 3 quarters · filed 2026-05-08 | $5.42M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.38M derived: sum of 2 quarters · filed 2026-03-09 | $1.52M derived: sum of 3 quarters · filed 2026-03-09 | -$612.19K 10-K · filed 2026-03-09 |
| 2024-09-30 | $475.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$380.16K derived: sum of 2 quarters · filed 2025-11-07 | -$2.52M 10-Q · filed 2025-11-07 | -$1.48M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$855.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$2.99M 10-Q · filed 2025-08-08 | -$1.95M derived: sum of 3 quarters · filed 2025-08-08 | -$715.64K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$2.14M 10-Q · filed 2025-05-09 | -$1.10M derived: sum of 2 quarters · filed 2025-05-09 | $140.02K derived: sum of 3 quarters · filed 2025-05-09 | $5.38M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.28M derived: sum of 2 quarters · filed 2025-03-07 | $7.51M derived: sum of 3 quarters · filed 2025-03-07 | $6.09M 10-K · filed 2025-03-07 |
| 2023-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $6.47M derived: sum of 2 quarters · filed 2024-11-08 | $5.05M 10-Q · filed 2024-11-08 | $8.69M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $5.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $3.82M 10-Q · filed 2024-08-09 | $7.46M derived: sum of 3 quarters · filed 2024-08-09 | $10.09M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$1.42M 10-Q · filed 2024-05-10 | $2.22M derived: sum of 2 quarters · filed 2024-05-10 | $4.86M derived: sum of 3 quarters · filed 2024-05-10 | $7.19M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $6.27M derived: sum of 2 quarters · filed 2024-03-13 | $8.60M derived: sum of 3 quarters · filed 2024-03-13 | $8.45M 10-K · filed 2024-03-13 |
| 2022-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $4.97M derived: sum of 2 quarters · filed 2023-11-13 | $4.82M 10-Q · filed 2023-11-13 | $6.78M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $2.18M 10-Q · filed 2023-08-11 | $4.14M derived: sum of 3 quarters · filed 2023-08-11 | $4.04M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$150.50K 10-Q · filed 2023-05-12 | $1.81M derived: sum of 2 quarters · filed 2023-05-12 | $1.71M derived: sum of 3 quarters · filed 2023-05-12 | $4.41M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $1.86M derived: sum of 2 quarters · filed 2023-03-13 | $4.56M derived: sum of 3 quarters · filed 2023-03-13 | $6.34M 10-K · filed 2023-03-13 |
| 2021-09-30 | -$102.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.60M derived: sum of 2 quarters · filed 2022-11-14 | $4.38M 10-Q · filed 2022-11-14 | $5.24M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $4.48M 10-Q · filed 2022-08-12 | $5.34M derived: sum of 3 quarters · filed 2022-08-12 | $6.20M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $1.79M 10-Q · filed 2022-05-13 | $2.64M derived: sum of 2 quarters · filed 2022-05-13 | $3.50M derived: sum of 3 quarters · filed 2022-05-13 | $6.31M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $853.92K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.71M derived: sum of 2 quarters · filed 2022-03-11 | $4.53M derived: sum of 3 quarters · filed 2022-03-11 | $5.42M 10-K · filed 2022-03-11 |
| 2020-09-30 | $857.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $3.67M derived: sum of 2 quarters · filed 2021-11-12 | $4.56M 10-Q · filed 2021-11-12 | $5.42M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $3.70M 10-Q · filed 2021-08-13 | $4.56M derived: sum of 3 quarters · filed 2022-03-11 | $5.30M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-03-31 | $888.54K 10-Q · filed 2021-05-14 | $1.75M derived: sum of 2 quarters · filed 2022-03-11 | $2.48M derived: sum of 3 quarters · filed 2022-03-11 | $4.33M derived: sum of 4 quarters · filed 2022-03-11 |
| 2019-12-31 | $857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.59M derived: sum of 2 quarters · filed 2022-03-11 | $3.44M derived: sum of 3 quarters · filed 2022-03-11 | $3.06M 10-K · filed 2022-03-11 |
| 2019-09-30 | $734.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $2.59M derived: sum of 2 quarters · filed 2020-11-13 | $2.20M 10-Q · filed 2020-11-13 | $5.92M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.46M 10-Q · filed 2020-08-14 | $5.19M derived: sum of 3 quarters · filed 2021-03-12 | $3.55M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$385.73K 10-Q · filed 2020-05-22 | $3.34M derived: sum of 2 quarters · filed 2021-03-12 | $1.70M derived: sum of 3 quarters · filed 2021-03-12 | $2.49M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.08M derived: sum of 2 quarters · filed 2021-03-12 | $2.88M derived: sum of 3 quarters · filed 2021-03-12 | $3.11M 10-K · filed 2021-03-12 |
| 2018-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$846.04K derived: sum of 2 quarters · filed 2019-11-13 | -$610.45K 10-Q · filed 2019-11-13 | -$1.07M derived: sum of 4 quarters · filed 2020-12-10 |
| 2018-06-30 | $794.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $1.03M 10-Q · filed 2019-08-14 | $570.11K derived: sum of 3 quarters · filed 2020-12-10 | $1.56M derived: sum of 4 quarters · filed 2020-12-10 |
| 2018-03-31 | $235.59K 10-Q · filed 2019-05-15 | -$223.97K derived: sum of 2 quarters · filed 2020-12-10 | $768.87K derived: sum of 3 quarters · filed 2020-12-10 | -$1.76M derived: sum of 4 quarters · filed 2020-12-10 |
| 2017-12-31 | -$459.56K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $533.28K derived: sum of 2 quarters · filed 2020-12-10 | -$2.00M derived: sum of 3 quarters · filed 2020-12-10 | -$557.71K 8-K · filed 2020-12-10 |
| 2017-09-30 | $992.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.54M derived: sum of 2 quarters · filed 2018-11-14 | -$98.15K 10-Q · filed 2018-11-14 | $721.64K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.09M 10-Q · filed 2018-08-14 | -$271.20K derived: sum of 3 quarters · filed 2019-03-12 | $22.42K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $1.44M 10-Q · filed 2018-05-09 | $2.26M derived: sum of 2 quarters · filed 2019-03-12 | $2.55M derived: sum of 3 quarters · filed 2019-03-12 | $1.41M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $819.79K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.11M derived: sum of 2 quarters · filed 2019-03-12 | -$29.01K derived: sum of 3 quarters · filed 2019-03-12 | $569.48K 10-K · filed 2019-03-12 |
| 2016-09-30 | $293.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$848.80K derived: sum of 2 quarters · filed 2017-11-08 | -$250.32K 10-Q · filed 2017-11-08 | $1.07M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$543.94K 10-Q · filed 2017-08-09 | $779.43K derived: sum of 3 quarters · filed 2018-03-09 | $1.27M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $598.49K 10-Q · filed 2017-05-15 | $1.92M derived: sum of 2 quarters · filed 2018-03-09 | $2.41M derived: sum of 3 quarters · filed 2018-03-09 | $4.44M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.81M derived: sum of 2 quarters · filed 2018-03-09 | $3.84M derived: sum of 3 quarters · filed 2018-03-09 | $5.88M 10-K · filed 2018-03-09 |
| 2015-09-30 | $485.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.52M derived: sum of 2 quarters · filed 2016-11-03 | $4.55M 10-Q · filed 2016-11-03 | $7.29M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $4.07M 10-Q · filed 2016-08-05 | $6.80M derived: sum of 3 quarters · filed 2017-03-13 | $8.94M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $2.03M 10-Q · filed 2016-05-13 | $4.77M derived: sum of 2 quarters · filed 2017-03-13 | $6.91M derived: sum of 3 quarters · filed 2017-03-13 | $7.74M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $4.88M derived: sum of 2 quarters · filed 2017-03-13 | $5.71M derived: sum of 3 quarters · filed 2017-03-13 | $6.69M 10-K · filed 2017-03-13 |
| 2014-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $2.98M derived: sum of 2 quarters · filed 2015-11-06 | $3.96M 10-Q · filed 2015-11-06 | $3.77M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $835.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.82M 10-Q · filed 2015-08-07 | $1.63M derived: sum of 3 quarters · filed 2016-03-14 | $772.19K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $982.57K 10-Q · filed 2015-05-15 | $789.94K derived: sum of 2 quarters · filed 2016-03-14 | -$63.63K derived: sum of 3 quarters · filed 2016-03-14 | $58.05K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | -$192.63K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$1.05M derived: sum of 2 quarters · filed 2016-03-14 | -$924.52K derived: sum of 3 quarters · filed 2016-03-14 | $746.13K 10-K · filed 2016-03-14 |
| 2013-09-30 | -$853.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$731.89K derived: sum of 2 quarters · filed 2014-11-07 | $938.76K 10-Q · filed 2014-11-07 | $2.93M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | $121.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $1.79M 10-Q · filed 2014-08-08 | $3.78M derived: sum of 3 quarters · filed 2015-03-09 | $5.68M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $1.67M 10-Q · filed 2014-05-12 | $3.66M derived: sum of 2 quarters · filed 2015-03-09 | $5.56M derived: sum of 3 quarters · filed 2015-03-09 | $6.20M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $3.89M derived: sum of 2 quarters · filed 2015-03-09 | $4.52M derived: sum of 3 quarters · filed 2015-03-09 | $7.14M 10-K · filed 2015-03-09 |
| 2012-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $2.54M derived: sum of 2 quarters · filed 2013-11-06 | $5.15M 10-Q · filed 2013-11-06 | $6.18M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | $634.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $3.25M 10-Q · filed 2013-08-09 | $4.28M derived: sum of 3 quarters · filed 2014-03-11 | $7.03M derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | $2.61M 10-Q · filed 2013-05-08 | $3.64M derived: sum of 2 quarters · filed 2014-03-11 | $6.40M derived: sum of 3 quarters · filed 2014-03-11 | $10.35M derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $3.79M derived: sum of 2 quarters · filed 2014-03-11 | $7.74M derived: sum of 3 quarters · filed 2014-03-11 | $8.72M 10-K · filed 2014-03-11 |
| 2011-09-30 | $2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $6.71M derived: sum of 2 quarters · filed 2012-11-02 | $7.69M 10-Q · filed 2012-11-02 | $7.01M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.94M 10-Q · filed 2012-08-09 | $4.25M derived: sum of 3 quarters · filed 2013-03-12 | $4.53M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $983.98K 10-Q · filed 2012-05-04 | $297.54K derived: sum of 2 quarters · filed 2013-03-12 | $575.48K derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | -$686.44K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$408.50K derived: sum of 2 quarters · filed 2013-03-12 | $346.66K 10-K · filed 2013-03-12 | |
| 2010-09-30 | $277.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.03M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $755.17K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $404.97K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |